TMDX Q2 2025 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$157M+37.7% YoY

Gross Profit

$97M61.4% margin

Operating Income

$37M23.2% margin

Net Income

$35M22.2% margin

EPS (Diluted)

$0.92

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

$92M

Free Cash Flow

$83M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$891M

Total Liabilities

$572M

Stockholders' Equity

$318M

Cash & Equivalents

$401M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$157M	$114M	+37.7%
Gross Profit	$97M	$69M	+39.7%
Operating Income	$37M	$13M	+192.3%
Net Income	$35M	$12M	+186.3%

Revenue Segments

Product

$96M61%

Service

$61M39%